Cargando…
Vitamin D(3) promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signaling
The β-catenin signaling pathway is deregulated in nearly all colon cancers. Nonhypercalcemic vitamin D3 (1α,25-dehydroxyvitamin D(3)) analogues are candidate drugs to treat this neoplasia. We show that these compounds promote the differentiation of human colon carcinoma SW480 cells expressing vitami...
Autores principales: | Pálmer, Héctor G., González-Sancho, José Manuel, Espada, Jesús, Berciano, María T., Puig, Isabel, Baulida, Josep, Quintanilla, Miguel, Cano, Amparo, de Herreros, Antonio García, Lafarga, Miguel, Muñoz, Alberto |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150773/ https://www.ncbi.nlm.nih.gov/pubmed/11470825 http://dx.doi.org/10.1083/jcb.200102028 |
Ejemplares similares
-
RhoA–ROCK and p38MAPK-MSK1 mediate vitamin D effects on gene expression, phenotype, and Wnt pathway in colon cancer cells
por: Ordóñez-Morán, Paloma, et al.
Publicado: (2008) -
Vitamin D Receptor Deficiency Enhances Wnt/β-Catenin Signaling and Tumor Burden in Colon Cancer
por: Larriba, María Jesús, et al.
Publicado: (2011) -
Novel Snail1 Target Proteins in Human Colon Cancer Identified by Proteomic Analysis
por: Larriba, María Jesús, et al.
Publicado: (2010) -
Gamma-Secretase-Dependent and -Independent Effects of Presenilin1 on β-Catenin·Tcf-4 Transcriptional Activity
por: Raurell, Imma, et al.
Publicado: (2008) -
Correction: Gamma-Secretase-Dependent and -Independent Effects of Presenilin1 on β-Catenin·Tcf-4 Transcriptional Activity
por: Raurell, Imma, et al.
Publicado: (2016)